查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402028

2030 年智慧胰島素筆針市場預測：按產品類型、適應症、可用性、連接性、最終用戶和地區進行的全球分析

Smart Insulin Pens Market Forecasts to 2030 - Global Analysis By Product, Type, Indication, Usability, Connectivity, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球智慧胰島素筆針市場規模為 1.1705 億美元，預計預測期內複合年成長率為 13.8%，到 2030 年將達到 2.8932 億美元。

智慧胰島素筆針將傳統胰島素給藥與現代技術結合，代表了糖尿病管理的革命性突破。此外，借助智慧型手機應用程式和藍牙連接，這些筆可讓使用者即時追蹤和監測胰島素給藥。除了為患者和醫療保健專業人員提供有關胰島素使用模式的有用見解之外，筆通常還包括資料儲存功能、個人化胰島素給藥建議和頻繁的給藥提醒。

根據國際糖尿病聯盟的數據，到 2021 年，大約有 5.37 億成年人（20 至 79 歲）將患有糖尿病。預計2030年糖尿病患者總數將增加至6.43億，2045年將增加至7.83億。

提高患者的依從性和參與度

促進患者醫囑遵從性和參與糖尿病治療的一個重要因素是使用智慧胰島素筆針。即時監測、個體化給藥建議和給藥提醒等功能使患者能夠積極參與他們的治療計劃。此外，透過促進控制感和課責，這些筆可以提高對建議的胰島素治療方案的醫囑遵從性，並降低與糖尿病管理不足相關的併發症的風險。

分配不公平和可近性有限

智慧胰島素筆針的供應有限是一個主要障礙，特別是在資源有限的地區和開發中國家。這些尖端設備的潛在好處的實現因分佈不均而受到阻礙，這可能導致獲得醫療保健的機會存在差異。此外，由於基礎設施、合格醫療人員的可用性和財務考量等問題，全球智慧胰島素筆針的採用並不一致。

糖尿病發生率上升和人口高齡化

由於全球人口高齡化和糖尿病盛行率同步上升，智慧胰島素筆針市場潛力巨大。老年人通常需要胰島素治療，而智慧筆易於使用的特點使他們感到舒適。此外，利用這些機會需要具體的行銷計劃和產品調整，以滿足老年人的獨特需求和偏好。

與傳統胰島素給藥法的競爭

注射器和筆等傳統胰島素輸送設備的持續廣泛接受和使用對智慧胰島素筆針構成了威脅。由於這些方法的既定用途和熟悉程度，採用更新的、技術先進的替代方案可能會遇到阻力。此外，為了應對這種危險，製造商應強調智慧胰島素筆針與傳統類型的獨特優勢和功能。

COVID-19 的影響：

智慧胰島素筆針市場受到 COVID-19 爆發的多方面影響。儘管在疫情期間醫療保健行業的關注和創新有所增加，但優先事項的變化、醫療保健服務的中斷以及經濟的不確定性影響了市場動態。世界對醫療保健技術和基礎設施（包括遠端患者監護）的日益關注創造了智慧胰島素筆針的機會。然而，供應鏈瓶頸、醫療措施延遲和衛生系統預算限制等問題阻礙了這些設備的普及。

智慧胰島素筆針預計在預測期內以最高速度成長

由於其尖端功能和無縫技術整合，智慧胰島素筆針預計將佔據智慧胰島素筆針市場的最大佔有率。這些筆透過藍牙連接和智慧型手機應用程式為用戶提供給藥提醒、資料追蹤和即時監控。此外，智慧胰島素筆針因其便利性和醫囑遵從性而成為患者和醫療保健提供者的首選，這也推動了普及。

預計居家照護產業在預測期內複合年成長率最高。

由於對居家醫療服務的需求不斷成長以及以患者為中心的護理趨勢，因此預計家庭護理設定行業的複合年成長率最高。隨著醫療保健技術的進步和患者尋求更個體化的護理，居家照護環境提供了一個實用且舒適的環境來管理各種醫療需求。它還包括醫療設備的使用、長期狀況監測和治療提供。

佔有率最大的地區：

由於醫療保健方面的大量投資、技術進步和強大的醫療保健基礎設施，預計北美將佔據最大的市場佔有率。主要製藥和醫療設備公司均位於美國，透過促進持續創新和推動市場成長，在該地區的主導地位中發揮關鍵作用。此外，由於政府舉措和有利的法規環境，北美市場的影響力越來越大。

複合年成長率最高的地區：

中東和非洲 (MEA) 地區的複合年成長率最高。該地區的醫療保健支出不斷增加，對醫療保健基礎設施的投資不斷增加，人們對醫療保健解決方案的認知也不斷提高。特別是在中東地區，各國正在改善醫療保健系統並引進尖端醫療技術。此外，該地區的顯著成長受到慢性病患病率和改善醫療保健結果的願望的影響。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球智慧胰島素筆針市場：依產品

  • 智慧胰島素筆針
  • 傳統筆適配器
  • 其他產品

第6章全球智慧胰島素筆針市場：按類型

  • 第一代筆
  • 第二代筆
  • 其他類型

第7章全球智慧型胰島素筆針市場：依跡象分類

  • I型糖尿病
  • II型糖尿病
  • 其他適應症

第8章全球智慧型胰島素筆針市場：依可用性

  • 填充
  • 可重複使用的

第9章全球智慧胰島素筆針市場：互聯性別

  • 藍牙連接
  • USB連接
  • 其他連接

第10章全球智慧胰島素筆針市場：依最終用戶分類

  • 診所及門診手術中心
  • 電子商務
  • 線上銷售
  • 家庭護理設置
  • 零售藥房
  • 其他最終用戶

第11章全球智慧胰島素筆針市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Companion Medical Inc.
  • Eli Lilly & Company
  • Diamesco Co. Ltd.
  • Jiangsu Deflu Medical Device Co. Ltd.
  • Berlin-Chemie
  • Medtronic PLC
  • Emperra GmbH
  • Digital Medics Pty Ltd.
  • Novo Nordisk A/S
  • Sanofi
  • Pendiq
  • Bigfoot Biomedical
Product Code: SMRC24548

According to Stratistics MRC, the Global Smart Insulin Pens Market is accounted for $117.05 million in 2023 and is expected to reach $289.32 million by 2030 growing at a CAGR of 13.8% during the forecast period. Smart insulin pens, which combine conventional insulin delivery with contemporary technology, represent a revolutionary breakthrough in the management of diabetes. Moreover, with the help of smartphone applications and Bluetooth connectivity, these pens allow users to track and monitor their insulin dosages in real time. In addition to providing patients and healthcare professionals with useful insights into insulin usage patterns, the pens frequently include data storage capabilities, personalized insulin dose recommendations, and dose reminders.

According to International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Market Dynamics:

Driver:

Increased compliance and involvement of patients

An essential factor in encouraging patient adherence and involvement in diabetes care is the use of smart insulin pens. Individuals are empowered to actively engage in their treatment plans through features like real-time monitoring, personalized dosage recommendations, and dose reminders. Additionally, these pens help improve adherence to recommended insulin regimens by encouraging a sense of control and accountability, which lowers the risk of complications linked to inadequate diabetes management.

Restraint:

Inequitable distribution and limited accessibility

The restricted availability of smart insulin pens presents a major obstacle, especially in areas with limited resources and developing nations. The realization of the potential benefits these cutting-edge devices offer may be hampered by unequal distribution, which could lead to disparities in healthcare access. Furthermore, the inconsistent implementation of smart insulin pens worldwide is a result of issues with infrastructure, the availability of qualified medical personnel, and economic considerations.

Opportunity:

Rising rate of diabetes and aging population

The market for smart insulin pens has a lot of potential due to the aging population on a global scale and the concurrent rise in diabetes prevalence. Insulin therapy is frequently necessary for older people, and smart pens' user-friendly features can make them comfortable. Moreover, in order to take advantage of these opportunities, specific marketing plans and product adjustments are needed to cater to the unique requirements and preferences of senior citizens.

Threat:

Conventional insulin delivery methods competition

The widespread acceptance and continued use of traditional insulin delivery devices, like syringes and pens, pose a threat to smart insulin pens. Adopting newer, technologically advanced alternatives may be met with resistance due to the established use and familiarity of these methods. Additionally, in order to counter this danger, manufacturers should emphasize the unique benefits and features that differentiate smart insulin pens from conventional models.

COVID-19 Impact:

The market for smart insulin pens has been impacted in a number of ways by the COVID-19 pandemic. Despite increased focus and innovation in the healthcare sector during the pandemic, changes in priorities, disruptions in healthcare access, and economic uncertainty impacted market dynamics. Opportunities for smart insulin pens were created by the increased focus on healthcare technology and infrastructure worldwide, including remote patient monitoring. However, issues like hiccups in the supply chain, postponed healthcare initiatives, and budgetary limitations in healthcare systems hindered the uptake of these gadgets.

The Smart Insulin Pens segment is expected to be the largest during the forecast period

Due to their cutting-edge features and seamless technological integration, smart insulin pens are expected to hold the largest share of the market in the smart insulin pens market. These pens provide users with dose reminders, data tracking, and real-time monitoring through Bluetooth connectivity and smartphone applications. Moreover, smart insulin pens are a preferred option for both patients and healthcare providers due to their convenience and increased adherence, which have fueled their widespread adoption.

The Home Care Settings segment is expected to have the highest CAGR during the forecast period

Due to the growing demand for in-home medical services and the trend towards patient-centric healthcare, the home care settings segment is predicted to have the highest CAGR. Home care settings provide a practical and comfortable setting for managing a range of medical needs as healthcare technologies advance and patients seek more individualized care. Additionally, this covers using medical devices, monitoring long-term conditions, and administering treatments.

Region with largest share:

Due in large part to its substantial investments in healthcare, technological advancements, and strong healthcare infrastructure, North America is expected to hold the largest market share. Major pharmaceutical and medical device companies are based in the United States, which plays a significant role in the region's dominance by promoting ongoing innovation and propelling market growth. Furthermore, North America is becoming more and more prominent due to government initiatives and a favorable regulatory environment.

Region with highest CAGR:

The Middle East and Africa (MEA) region has the highest CAGR in the market. The area is seeing a rise in healthcare spending, a rise in investments in healthcare infrastructure, and a rise in awareness of healthcare solutions. Particularly in the Middle East, nations are improving their healthcare systems and embracing cutting-edge medical technology. Moreover, the region's significant growth is influenced by the prevalence of chronic diseases and the desire for improved healthcare outcomes.

Key players in the market:

Some of the key players in Smart Insulin Pens market include Companion Medical Inc., Eli Lilly & Company, Diamesco Co. Ltd., Jiangsu Deflu Medical Device Co. Ltd., Berlin-Chemie, Medtronic PLC, Emperra GmbH, Digital Medics Pty Ltd., Novo Nordisk A/S, Sanofi, Pendiq and Bigfoot Biomedical.

Key Developments:

In November 2023, Medtronic announced today that it launched its Penditure left atrial appendage (LAA) exclusion system in the U.S. Penditure, an implantable chip, comes pre-loaded on a single-use delivery system for LAA management during concomitant cardiac surgery procedures. Medtronic designed it with a curve to better match atrial anatomy and without fabric for atraumatic closure and reduced inflammation.

In August 2023, Novo Nordisk A/S has agreed to acquire Inversago Pharma for up to $1.075 billion. Inversago Pharma is developing CB1 receptor-based therapies for the potential treatment of obesity, diabetes and complications associated with metabolic disorders.

In July 2023, Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling.

Products Covered:

  • Smart Insulin Pens
  • Adaptors for Conventional Pens
  • Other Products

Types Covered:

  • First Generation Pens
  • Second Generation Pens
  • Other Types

Indications Covered:

  • Diabetes Type I
  • Diabetes Type II
  • Other Indications

Usabilities Covered:

  • Prefilled
  • Reusable

Connectivities Covered:

  • Bluetooth Connected
  • USB Connected
  • Other Connectivities

End Users Covered:

  • Clinics & Ambulatory Surgical Centers
  • E-Commerce
  • Online Sales
  • Home Care Settings
  • Retail Pharmacies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Smart Insulin Pens Market, By Product

  • 5.1 Introduction
  • 5.2 Smart Insulin Pens
  • 5.3 Adaptors for Conventional Pens
  • 5.4 Other Products

6 Global Smart Insulin Pens Market, By Type

  • 6.1 Introduction
  • 6.2 First Generation Pens
  • 6.3 Second Generation Pens
  • 6.4 Other Types

7 Global Smart Insulin Pens Market, By Indication

  • 7.1 Introduction
  • 7.2 Diabetes Type I
  • 7.3 Diabetes Type II
  • 7.4 Other Indications

8 Global Smart Insulin Pens Market, By Usability

  • 8.1 Introduction
  • 8.2 Prefilled
  • 8.3 Reusable

9 Global Smart Insulin Pens Market, By Connectivity

  • 9.1 Introduction
  • 9.2 Bluetooth Connected
  • 9.3 USB Connected
  • 9.4 Other Connectivities

10 Global Smart Insulin Pens Market, By End User

  • 10.1 Introduction
  • 10.2 Clinics & Ambulatory Surgical Centers
  • 10.3 E-Commerce
  • 10.4 Online Sales
  • 10.5 Home Care Settings
  • 10.6 Retail Pharmacies
  • 10.7 Other End Users

11 Global Smart Insulin Pens Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Companion Medical Inc.
  • 13.2 Eli Lilly & Company
  • 13.3 Diamesco Co. Ltd.
  • 13.4 Jiangsu Deflu Medical Device Co. Ltd.
  • 13.5 Berlin-Chemie
  • 13.6 Medtronic PLC
  • 13.7 Emperra GmbH
  • 13.8 Digital Medics Pty Ltd.
  • 13.9 Novo Nordisk A/S
  • 13.10 Sanofi
  • 13.11 Pendiq
  • 13.12 Bigfoot Biomedical

List of Tables

  • Table 1 Global Smart Insulin Pens Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Smart Insulin Pens Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Smart Insulin Pens Market Outlook, By Smart Insulin Pens (2021-2030) ($MN)
  • Table 4 Global Smart Insulin Pens Market Outlook, By Adaptors for Conventional Pens (2021-2030) ($MN)
  • Table 5 Global Smart Insulin Pens Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Smart Insulin Pens Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Smart Insulin Pens Market Outlook, By First Generation Pens (2021-2030) ($MN)
  • Table 8 Global Smart Insulin Pens Market Outlook, By Second Generation Pens (2021-2030) ($MN)
  • Table 9 Global Smart Insulin Pens Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 10 Global Smart Insulin Pens Market Outlook, By Indication (2021-2030) ($MN)
  • Table 11 Global Smart Insulin Pens Market Outlook, By Diabetes Type I (2021-2030) ($MN)
  • Table 12 Global Smart Insulin Pens Market Outlook, By Diabetes Type II (2021-2030) ($MN)
  • Table 13 Global Smart Insulin Pens Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 14 Global Smart Insulin Pens Market Outlook, By Usability (2021-2030) ($MN)
  • Table 15 Global Smart Insulin Pens Market Outlook, By Prefilled (2021-2030) ($MN)
  • Table 16 Global Smart Insulin Pens Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 17 Global Smart Insulin Pens Market Outlook, By Connectivity (2021-2030) ($MN)
  • Table 18 Global Smart Insulin Pens Market Outlook, By Bluetooth Connected (2021-2030) ($MN)
  • Table 19 Global Smart Insulin Pens Market Outlook, By USB Connected (2021-2030) ($MN)
  • Table 20 Global Smart Insulin Pens Market Outlook, By Other Connectivities (2021-2030) ($MN)
  • Table 21 Global Smart Insulin Pens Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Smart Insulin Pens Market Outlook, By Clinics & Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Smart Insulin Pens Market Outlook, By E-Commerce (2021-2030) ($MN)
  • Table 24 Global Smart Insulin Pens Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 25 Global Smart Insulin Pens Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 26 Global Smart Insulin Pens Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 27 Global Smart Insulin Pens Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.